Nektar Therapeutics (NKTR)
USD 0.56
(-6.09%)
USD 0.56
(-6.09%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 112.62 Million USD | -0.18% |
| 2022 | 112.82 Million USD | -10.27% |
| 2021 | 125.73 Million USD | -7.8% |
| 2020 | 136.37 Million USD | -4.45% |
| 2019 | 142.73 Million USD | -42.2% |
| 2018 | 246.95 Million USD | 0.71% |
| 2017 | 245.2 Million USD | -0.2% |
| 2016 | 245.68 Million USD | 1.03% |
| 2015 | 243.18 Million USD | 88.31% |
| 2014 | 129.13 Million USD | -2.94% |
| 2013 | 133.04 Million USD | -2.6% |
| 2012 | 136.6 Million USD | 836.82% |
| 2011 | 14.58 Million USD | -93.71% |
| 2010 | 231.96 Million USD | -0.76% |
| 2009 | 233.75 Million USD | -0.66% |
| 2008 | 235.3 Million USD | -30.1% |
| 2007 | 336.63 Million USD | 0.56% |
| 2006 | 334.75 Million USD | -23.56% |
| 2005 | 437.92 Million USD | 121.72% |
| 2004 | 197.51 Million USD | -49.57% |
| 2003 | 391.67 Million USD | 18.33% |
| 2002 | 331.01 Million USD | -0.01% |
| 2001 | 331.05 Million USD | 3.69% |
| 2000 | 319.26 Million USD | 181.68% |
| 1999 | 113.34 Million USD | 2194.43% |
| 1998 | 4.94 Million USD | -3.18% |
| 1997 | 5.1 Million USD | 2451.0% |
| 1996 | 200 Thousand USD | -50.0% |
| 1995 | 400 Thousand USD | -20.0% |
| 1994 | 500 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 117.85 Million USD | 0.0% |
| 2024 Q2 | 107.5 Million USD | -100.0% |
| 2023 Q2 | 105.81 Million USD | -3.27% |
| 2023 Q1 | 109.38 Million USD | -3.05% |
| 2023 FY | 112.62 Million USD | -0.18% |
| 2023 Q3 | 102.19 Million USD | -3.42% |
| 2023 Q4 | 112.62 Million USD | 10.21% |
| 2022 Q2 | 119.41 Million USD | -2.63% |
| 2022 Q3 | 116.14 Million USD | -2.74% |
| 2022 Q1 | 122.63 Million USD | -2.46% |
| 2022 FY | 112.82 Million USD | -10.27% |
| 2022 Q4 | 112.82 Million USD | -2.86% |
| 2021 Q4 | 125.73 Million USD | -2.32% |
| 2021 FY | 125.73 Million USD | -7.8% |
| 2021 Q1 | 134.55 Million USD | -1.33% |
| 2021 Q2 | 131.65 Million USD | -2.15% |
| 2021 Q3 | 128.71 Million USD | -2.23% |
| 2020 Q3 | 139.02 Million USD | -1.84% |
| 2020 Q2 | 141.63 Million USD | -0.47% |
| 2020 FY | 136.37 Million USD | -4.45% |
| 2020 Q4 | 136.37 Million USD | -1.91% |
| 2020 Q1 | 142.29 Million USD | -0.3% |
| 2019 FY | 142.73 Million USD | -42.2% |
| 2019 Q3 | 393.35 Million USD | 14.8% |
| 2019 Q4 | 142.73 Million USD | -63.71% |
| 2019 Q1 | 342.41 Million USD | 38.66% |
| 2019 Q2 | 342.64 Million USD | 0.07% |
| 2018 Q2 | 246.07 Million USD | 0.18% |
| 2018 Q4 | 246.95 Million USD | 0.18% |
| 2018 FY | 246.95 Million USD | 0.71% |
| 2018 Q1 | 245.64 Million USD | 0.18% |
| 2018 Q3 | 246.51 Million USD | 0.18% |
| 2017 FY | 245.2 Million USD | -0.2% |
| 2017 Q4 | 245.2 Million USD | 0.18% |
| 2017 Q3 | 244.77 Million USD | -0.25% |
| 2017 Q2 | 245.39 Million USD | -0.05% |
| 2017 Q1 | 245.5 Million USD | -0.07% |
| 2016 Q3 | 245.14 Million USD | -0.07% |
| 2016 Q1 | 245.45 Million USD | 0.93% |
| 2016 Q2 | 245.32 Million USD | -0.05% |
| 2016 FY | 245.68 Million USD | 1.03% |
| 2016 Q4 | 245.68 Million USD | 0.22% |
| 2015 Q4 | 243.18 Million USD | 18116.33% |
| 2015 Q1 | 129.38 Million USD | 0.19% |
| 2015 Q3 | 1.33 Million USD | -98.96% |
| 2015 FY | 243.18 Million USD | 88.31% |
| 2015 Q2 | 127.88 Million USD | -1.16% |
| 2014 FY | 129.13 Million USD | -2.94% |
| 2014 Q2 | 131.02 Million USD | -0.78% |
| 2014 Q3 | 130.33 Million USD | -0.52% |
| 2014 Q1 | 132.05 Million USD | -0.75% |
| 2014 Q4 | 129.13 Million USD | -0.92% |
| 2013 Q1 | 135.76 Million USD | -0.62% |
| 2013 Q3 | 134 Million USD | -0.66% |
| 2013 FY | 133.04 Million USD | -2.6% |
| 2013 Q4 | 133.04 Million USD | -0.71% |
| 2013 Q2 | 134.9 Million USD | -0.64% |
| 2012 Q3 | 137.41 Million USD | 943.07% |
| 2012 Q1 | 13.89 Million USD | -4.75% |
| 2012 FY | 136.6 Million USD | 836.82% |
| 2012 Q4 | 136.6 Million USD | -0.59% |
| 2012 Q2 | 13.17 Million USD | -5.15% |
| 2011 Q3 | 15.25 Million USD | -93.39% |
| 2011 Q2 | 230.81 Million USD | -0.25% |
| 2011 Q1 | 231.4 Million USD | -0.24% |
| 2011 FY | 14.58 Million USD | -93.71% |
| 2011 Q4 | 14.58 Million USD | -4.38% |
| 2010 Q1 | 233.3 Million USD | -0.19% |
| 2010 FY | 231.96 Million USD | -0.76% |
| 2010 Q4 | 231.96 Million USD | -0.17% |
| 2010 Q3 | 232.35 Million USD | -0.21% |
| 2010 Q2 | 232.84 Million USD | -0.2% |
| 2009 Q2 | 234.57 Million USD | -0.16% |
| 2009 FY | 233.75 Million USD | -0.66% |
| 2009 Q3 | 234.18 Million USD | -0.17% |
| 2009 Q1 | 234.94 Million USD | -0.15% |
| 2009 Q4 | 233.75 Million USD | -0.18% |
| 2008 Q4 | 235.3 Million USD | -29.9% |
| 2008 Q1 | 336.33 Million USD | -0.09% |
| 2008 Q2 | 336.01 Million USD | -0.09% |
| 2008 Q3 | 335.68 Million USD | -0.1% |
| 2008 FY | 235.3 Million USD | -30.1% |
| 2007 Q2 | 334.32 Million USD | -0.07% |
| 2007 Q4 | 336.63 Million USD | -0.11% |
| 2007 Q3 | 336.98 Million USD | 0.8% |
| 2007 FY | 336.63 Million USD | 0.56% |
| 2007 Q1 | 334.54 Million USD | -0.06% |
| 2006 Q1 | 401.75 Million USD | -8.26% |
| 2006 Q3 | 401.44 Million USD | -0.04% |
| 2006 Q4 | 334.75 Million USD | -16.61% |
| 2006 FY | 334.75 Million USD | -23.56% |
| 2006 Q2 | 401.6 Million USD | -0.04% |
| 2005 Q3 | 438.07 Million USD | 125.25% |
| 2005 FY | 437.92 Million USD | 121.72% |
| 2005 Q1 | 194.59 Million USD | -1.48% |
| 2005 Q2 | 194.48 Million USD | -0.06% |
| 2005 Q4 | 437.92 Million USD | -0.03% |
| 2004 FY | 197.51 Million USD | -49.57% |
| 2004 Q4 | 197.51 Million USD | -0.09% |
| 2004 Q3 | 197.69 Million USD | -3.29% |
| 2004 Q2 | 204.42 Million USD | -3.93% |
| 2004 Q1 | 212.77 Million USD | -45.67% |
| 2003 Q2 | 409.69 Million USD | 23.91% |
| 2003 Q1 | 330.63 Million USD | -0.11% |
| 2003 Q3 | 419.19 Million USD | 2.32% |
| 2003 FY | 391.67 Million USD | 18.33% |
| 2003 Q4 | 391.67 Million USD | -6.56% |
| 2002 Q3 | 331.49 Million USD | 0.16% |
| 2002 Q1 | 330.82 Million USD | -0.07% |
| 2002 Q4 | 331.01 Million USD | -0.14% |
| 2002 FY | 331.01 Million USD | -0.01% |
| 2002 Q2 | 330.95 Million USD | 0.04% |
| 2001 Q1 | 317.94 Million USD | -0.42% |
| 2001 Q2 | 325.48 Million USD | 2.37% |
| 2001 Q3 | 328.76 Million USD | 1.01% |
| 2001 Q4 | 331.05 Million USD | 0.7% |
| 2001 FY | 331.05 Million USD | 3.69% |
| 2000 Q4 | 319.26 Million USD | 31.59% |
| 2000 Q3 | 242.62 Million USD | -0.0% |
| 2000 Q1 | 244.64 Million USD | 115.84% |
| 2000 Q2 | 242.63 Million USD | -0.82% |
| 2000 FY | 319.26 Million USD | 181.68% |
| 1999 Q3 | 4.9 Million USD | -0.26% |
| 1999 Q4 | 113.34 Million USD | 2211.28% |
| 1999 Q2 | 4.91 Million USD | -0.16% |
| 1999 Q1 | 4.92 Million USD | -0.3% |
| 1999 FY | 113.34 Million USD | 2194.43% |
| 1998 FY | 4.94 Million USD | -3.18% |
| 1998 Q2 | 4.97 Million USD | -2.24% |
| 1998 Q1 | 5.08 Million USD | -0.27% |
| 1998 Q4 | 4.94 Million USD | -0.34% |
| 1998 Q3 | 4.95 Million USD | -0.34% |
| 1997 Q3 | 148 Thousand USD | -8.64% |
| 1997 FY | 5.1 Million USD | 2451.0% |
| 1997 Q1 | 175 Thousand USD | -12.5% |
| 1997 Q2 | 162 Thousand USD | -7.43% |
| 1997 Q4 | 5.1 Million USD | 3347.3% |
| 1996 Q1 | 300 Thousand USD | -25.0% |
| 1996 Q4 | 200 Thousand USD | 0.0% |
| 1996 Q3 | 200 Thousand USD | -33.33% |
| 1996 FY | 200 Thousand USD | -50.0% |
| 1996 Q2 | 300 Thousand USD | 0.0% |
| 1995 Q3 | 300 Thousand USD | 0.0% |
| 1995 FY | 400 Thousand USD | -20.0% |
| 1995 Q2 | 300 Thousand USD | -25.0% |
| 1995 Q1 | 400 Thousand USD | -20.0% |
| 1995 Q4 | 400 Thousand USD | 33.33% |
| 1994 FY | 500 Thousand USD | 0.0% |
| 1994 Q2 | 600 Thousand USD | 0.0% |
| 1994 Q3 | - USD | -100.0% |
| 1994 Q1 | 600 Thousand USD | 0.0% |
| 1994 Q4 | 500 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -58.132% |
| Alkermes plc | 287.73 Million USD | 60.857% |
| Agenus Inc. | 137.32 Million USD | 17.986% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 95.193% |
| Aptorum Group Limited | 3.05 Million USD | -3582.361% |
| Ardelyx, Inc. | 51.54 Million USD | -118.49% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -7.664% |
| Bicycle Therapeutics plc | 40.08 Million USD | -181.0% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -11.956% |
| ChromaDex Corporation | 2.57 Million USD | -4273.786% |
| Chimerix, Inc. | 125 Thousand USD | -90000.0% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -3377.55% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -334.711% |
| CRISPR Therapeutics AG | 223 Million USD | 49.497% |
| Precision BioSciences, Inc. | 7.72 Million USD | -1358.306% |
| Dyadic International, Inc. | 88.87 Thousand USD | -126630.055% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -511831.818% |
| Fortress Biotech, Inc. | 60.85 Million USD | -85.068% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -183041.993% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -2863.036% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -124866.713% |
| Incyte Corporation | 29.16 Million USD | -286.205% |
| IO Biotech, Inc. | 1.83 Million USD | -6024.252% |
| Jaguar Health, Inc. | 30.99 Million USD | -263.389% |
| Novavax, Inc. | 168.01 Million USD | 32.968% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -389.142% |
| Opthea Limited | 200.53 Million USD | 43.838% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -1856.994% |
| ContextLogic Inc. | 6 Million USD | -1777.083% |
| MiMedx Group, Inc. | 48.09 Million USD | -134.152% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -460.351% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -294029.169% |
| NextCure, Inc. | 5.94 Million USD | -1793.175% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -77572.414% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -409.362% |
| PDS Biotechnology Corporation | 19.5 Million USD | -477.381% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | 2.472% |
| Pharming Group N.V. | 166.1 Million USD | 32.197% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -1712.731% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -236.044% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -9238.723% |
| Acelyrin, Inc. | 1.19 Million USD | -9332.58% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -24383.696% |
| Summit Therapeutics Inc. | 103.29 Million USD | -9.038% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -2888.193% |
| Senti Biosciences, Inc. | 33.53 Million USD | -235.813% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -2259.627% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -225.92% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -86.709% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -7073.567% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -343.336% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -7.942% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -15285.929% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -906.389% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | 18.567% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -738.046% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -650.833% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | 41.013% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -113.88% |
| Fortress Biotech, Inc. | 60.85 Million USD | -85.068% |
| Precigen, Inc. | 5.89 Million USD | -1810.517% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -168.231% |
| AlloVir, Inc. | 16.64 Million USD | -576.508% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -71.275% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -15.679% |
| ImmuCell Corporation | 10.54 Million USD | -968.498% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -9911.111% |
| Onconetix, Inc. | 118.85 Thousand USD | -94656.724% |
| PureTech Health plc | 18.25 Million USD | -517.123% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -113662.626% |
| Elevation Oncology, Inc. | 30.13 Million USD | -273.71% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -333.774% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -162.688% |
| Innoviva, Inc. | 446.23 Million USD | 74.761% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -13420.408% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -168389.318% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | 45.583% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -58.19% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -3432.779% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -10750.193% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -404.457% |
| Aptose Biosciences Inc. | 621 Thousand USD | -18036.071% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -11040.688% |
| Century Therapeutics, Inc. | 46.65 Million USD | -141.384% |
| Kura Oncology, Inc. | 9.33 Million USD | -1106.869% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -321.816% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -81512.319% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -1100.053% |
| Autolus Therapeutics plc | 47.91 Million USD | -135.057% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -2195.658% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -1562.853% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | 13.803% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -1289.574% |
| IGM Biosciences, Inc. | 34.67 Million USD | -224.83% |
| INmune Bio, Inc. | 397 Thousand USD | -28269.018% |
| Heron Therapeutics, Inc. | 173.75 Million USD | 35.181% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -2677.942% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -76542.236% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -126.282% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -106.386% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -146.482% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 76.208% |
| Verastem, Inc. | 40.08 Million USD | -180.958% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -2458.496% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -1020.201% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -1616.583% |
| Histogen Inc. | 4.38 Million USD | -2469.001% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -12669.274% |
| Organovo Holdings, Inc. | 888 Thousand USD | -12582.995% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -275.417% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -2585.384% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -496.057% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -48.778% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -120866.876% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -334.728% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -42081.648% |
| Amarin Corporation plc | 8.73 Million USD | -1189.058% |
| Mesoblast Limited | 100.48 Million USD | -12.084% |
| Turnstone Biologics Corp. | 1.18 Million USD | -9372.246% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -43.785% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -103225.688% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -37.332% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | 40.706% |
| Better Therapeutics, Inc. | 10.34 Million USD | -988.375% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -387.027% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -21.059% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -8617.105% |
| Gritstone bio, Inc. | 40.14 Million USD | -180.553% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -6108.655% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | 26.673% |
| Insmed Incorporated | 1.19 Billion USD | 90.562% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -1673.622% |
| OmniAb, Inc. | 22.07 Million USD | -410.193% |
| Alector, Inc. | 30.45 Million USD | -269.796% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -10.913% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -1299.59% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 73.599% |
| Aura Biosciences, Inc. | 16.87 Million USD | -567.605% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -97.956% |
| Immunic, Inc. | 639 Thousand USD | -17525.196% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -277.695% |
| Veracyte, Inc. | 7.52 Million USD | -1396.678% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 82.535% |
| FibroGen, Inc. | 89.69 Million USD | -25.562% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -2496.841% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -85963.288% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 97.795% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -304291.892% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -5588.131% |
| TG Therapeutics, Inc. | 100.11 Million USD | -12.492% |
| Galecto, Inc. | 66 Thousand USD | -170543.939% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -82712.5% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 93.101% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -1772.402% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -1986.807% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -6108.655% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -425.132% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -208.097% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -21684.333% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -148.972% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -268.369% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -151.384% |
| Vaxxinity, Inc. | 13.26 Million USD | -749.231% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 86.117% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -24980.558% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -1181.431% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 95.833% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -35540.823% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -2426.357% |
| Ainos, Inc. | 5.92 Million USD | -1801.949% |
| Pluri Inc. | 29.05 Million USD | -287.654% |
| Prothena Corporation plc | 10.72 Million USD | -950.508% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -467.352% |
| Celularity Inc. | 26.17 Million USD | -330.244% |
| Rallybio Corporation | 173 Thousand USD | -65001.156% |
| Cue Biopharma, Inc. | 4.2 Million USD | -2580.271% |
| MeiraGTx Holdings plc | 72.11 Million USD | -56.166% |
| Omeros Corporation | 329.7 Million USD | 65.841% |
| Humacyte, Inc. | 38.6 Million USD | -191.775% |
| Immunocore Holdings plc | 82.64 Million USD | -36.277% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -6882.331% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -3048.588% |
| Blueprint Medicines Corporation | 610.96 Million USD | 81.566% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -7624.623% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -18.317% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -131.339% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -23.899% |
| Pulmatrix, Inc. | 8.32 Million USD | -1252.528% |
| Elicio Therapeutics, Inc. | 6 Million USD | -1774.896% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -770.027% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -16.412% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -23913.859% |
| Cytokinetics, Incorporated | 607.37 Million USD | 81.457% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -1195.732% |
| Nutriband Inc. | 79.82 Thousand USD | -140988.117% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -2411.708% |
| Vor Biopharma Inc. | 31.83 Million USD | -253.833% |
| Roivant Sciences Ltd. | 477.85 Million USD | 76.431% |
| Evogene Ltd. | 10.65 Million USD | -957.214% |
| ProKidney Corp. | 3.61 Million USD | -3019.806% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -14738.603% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -427709.01% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 93.511% |
| CorMedix Inc. | 517.01 Thousand USD | -21683.785% |
| BioLineRx Ltd. | 6.62 Million USD | -1599.231% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -205.73% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -56.988% |
| Atai Life Sciences N.V. | 15.21 Million USD | -640.418% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -13269.714% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -44066.667% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -161.008% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -27325.364% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -8126.808% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -16884.643% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | 36.752% |
| Biomea Fusion, Inc. | 7.83 Million USD | -1338.378% |
| PTC Therapeutics, Inc. | 284.21 Million USD | 60.373% |
| Mereo BioPharma Group plc | 5.3 Million USD | -2025.0% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -5138.372% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -19053.912% |
| Absci Corporation | 4.66 Million USD | -2316.845% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -877.478% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -396.255% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -1025.687% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -878.922% |
| Allakos Inc. | 38.21 Million USD | -194.714% |
| Imunon, Inc. | 1.13 Million USD | -9785.517% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -1205.192% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -13371.89% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -1126150.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -27.482% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -2291.697% |
| XOMA Corporation | 118.51 Million USD | 4.972% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -1018.532% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -203.743% |
| aTyr Pharma, Inc. | 13.76 Million USD | -718.079% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -1325.813% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -351.15% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -457.412% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -750733.333% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -40384.92% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -679.15% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 92.488% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -82607.291% |
| UroGen Pharma Ltd. | 98.55 Million USD | -14.281% |
| Sutro Biopharma, Inc. | 149.11 Million USD | 24.471% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -490.68% |
| Entera Bio Ltd. | 256 Thousand USD | -43894.141% |
| GH Research PLC | 631 Thousand USD | -17748.653% |
| Lisata Therapeutics, Inc. | 137.00 USD | -82207929.197% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -17442.835% |
| Xencor, Inc. | 14.64 Million USD | -669.191% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -74857.904% |
| Replimune Group, Inc. | 71.99 Million USD | -56.445% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -74983.333% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -1507.551% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -82607.291% |
| Portage Biotech Inc. | 7000.00 USD | -1608828.571% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -16884.643% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -7781.386% |
| OncoCyte Corporation | 2.2 Million USD | -5010.027% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -168235.7% |
| Purple Biotech Ltd. | 163 Thousand USD | -68995.092% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -4342.801% |
| scPharmaceuticals Inc. | 38.81 Million USD | -190.188% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -346.146% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -154180.822% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -5977.982% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -327.452% |
| Curis, Inc. | 1.48 Million USD | -7463.801% |
| Daré Bioscience, Inc. | 3.91 Million USD | -2777.729% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -16041.978% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -1876983.333% |
| BeiGene, Ltd. | 197.61 Million USD | 43.009% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -12256.007% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -39.777% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -117.05% |
| bluebird bio, Inc. | 224.41 Million USD | 49.815% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 81.011% |
| DBV Technologies S.A. | 4.52 Million USD | -2388.4% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -8304.851% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -1056.077% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -2889.78% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 70.147% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -162.67% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -6459.406% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -12036.315% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -544.787% |
| MacroGenics, Inc. | 30.19 Million USD | -272.98% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -536.192% |
| Prime Medicine, Inc. | 4.35 Million USD | -2484.921% |
| Aditxt, Inc. | 1.04 Million USD | -10711.197% |
| Adagene Inc. | 13.54 Million USD | -731.793% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -719.866% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 78.287% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -558.895% |
| SciSparc Ltd. | 24 Thousand USD | -469170.833% |
| Vericel Corporation | 81.85 Million USD | -37.589% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -37.319% |
| Generation Bio Co. | 89.77 Million USD | -25.454% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -407.663% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | 44.19% |
| Invivyd, Inc. | 722 Thousand USD | -15499.03% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -132.207% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -3851999.886% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -2844.444% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -489573.913% |
| 2seventy bio, Inc. | 244.01 Million USD | 53.845% |
| ADMA Biologics, Inc. | 130.59 Million USD | 13.759% |
| Clene Inc. | 7.15 Million USD | -1474.734% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -3235.793% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | 54.516% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -10129.337% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -42745.187% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | 41.53% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -296.525% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -1068.43% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -0.852% |
| Evaxion Biotech A/S | 8.48 Million USD | -1226.756% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -50.317% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -74.032% |
| Trevena, Inc. | 35.23 Million USD | -219.658% |
| Surrozen, Inc. | 882 Thousand USD | -12669.274% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -1711.856% |
| Cingulate Inc. | 135.09 Thousand USD | -83264.792% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -378.461% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -135.617% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -62469.444% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -343.772% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -545.897% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -11932.585% |
| Statera Biopharma, Inc. | 11.43 Million USD | -885.247% |
| ImmunityBio, Inc. | 836.95 Million USD | 86.543% |
| Korro Bio, Inc. | 31.21 Million USD | -260.793% |
| Kineta, Inc. | 150 Thousand USD | -74983.333% |
| BioVie Inc. | 349.89 Thousand USD | -32088.32% |
| Codexis, Inc. | 12.24 Million USD | -819.913% |
| Celularity Inc. | 26.17 Million USD | -330.244% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -136.831% |
| Celcuity Inc. | 37.03 Million USD | -204.101% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -63766.285% |
| Cibus, Inc. | 17.67 Million USD | -537.235% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -3233.087% |
| Kodiak Sciences Inc. | 100 Million USD | -12.625% |
| Annexon, Inc. | 29.19 Million USD | -285.834% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -74.269% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -9937.879% |
| Avalo Therapeutics, Inc. | 2 Million USD | -5531.25% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 91.958% |
| Eyenovia, Inc. | 8.95 Million USD | -1157.364% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -71.53% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -1283.26% |
| Arcellx, Inc. | 50.84 Million USD | -121.524% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -7624.623% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -430.299% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -10575.355% |
| Moolec Science SA | 99.04 Thousand USD | -113609.791% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -307.751% |
| Geron Corporation | 35.05 Million USD | -221.318% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -18956.684% |
| Royalty Pharma plc | 6.13 Billion USD | 98.164% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -6759.013% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -354713.811% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -386.543% |
| Humacyte, Inc. | 38.6 Million USD | -191.775% |
| Structure Therapeutics Inc. | 4.01 Million USD | -2706.504% |
| 89bio, Inc. | 24.79 Million USD | -354.225% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -805.783% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -5935.638% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -10813.275% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -13.182% |
| Notable Labs, Ltd. | 1.52 Million USD | -7280.406% |
| Liquidia Corporation | 2.36 Million USD | -4664.171% |
| Mustang Bio, Inc. | 1.97 Million USD | -5593.883% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -719.866% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -1519.804% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -35428.391% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -125.805% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -1072.688% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -171875.446% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -82712.5% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -1697.973% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -86534.615% |
| PepGen Inc. | 17.1 Million USD | -558.626% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -23660.549% |
| United Therapeutics Corporation | 300 Million USD | 62.458% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -370.427% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -2605.477% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -19385.294% |
| XOMA Corporation | 118.51 Million USD | 4.972% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -304291.892% |
| Bionomics Limited | 117.62 Million USD | 4.253% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -11971.275% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -1907.576% |
| uniQure N.V. | 130.06 Million USD | 13.409% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -92.226% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -16317.638% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -2496.841% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -8031.769% |
| Altimmune, Inc. | 175 Thousand USD | -64257.143% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 70.962% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -1907.576% |
| Compugen Ltd. | 719 Thousand USD | -15564.117% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -2123.154% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -33.197% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -1034.189% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -1665.559% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -23.209% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -1034.189% |
| Instil Bio, Inc. | 81.42 Million USD | -38.314% |
| argenx SE | 15.35 Million USD | -633.522% |
| Immunome, Inc. | 1.34 Million USD | -8304.851% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -20912.127% |
| Verona Pharma plc | 48.37 Million USD | -132.821% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -1122.059% |
| Shattuck Labs, Inc. | 3.4 Million USD | -3206.665% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -132400.0% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -66938.69% |
| Moolec Science SA | 99.04 Thousand USD | -113609.791% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -920.888% |
| AnaptysBio, Inc. | 16.03 Million USD | -602.282% |
| Design Therapeutics, Inc. | 2.33 Million USD | -4725.407% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -415935.61% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -1777.083% |
| Achilles Therapeutics plc | 1.07 Million USD | -10367.007% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -1122.059% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -564832.785% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -572.692% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -140988.117% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -1509416.151% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -866246.154% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | 67.115% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -359.994% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -4405.018% |
| Palisade Bio, Inc. | 90 Thousand USD | -125038.889% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -57954.124% |
| Beam Therapeutics Inc. | 159.91 Million USD | 29.57% |
| Neurogene Inc. | 13.37 Million USD | -742.182% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | 63.245% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -328.835% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -188166.858% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -11162.5% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -178.031% |
| Athira Pharma, Inc. | 1.21 Million USD | -9154.314% |
| Vaccinex, Inc. | 26 Thousand USD | -433073.077% |
| HCW Biologics Inc. | 6.3 Million USD | -1686.474% |
| XOMA Corporation | 118.51 Million USD | 4.972% |
| Arvinas, Inc. | 800 Thousand USD | -13978.125% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -679.15% |
| Merus N.V. | 10.48 Million USD | -973.846% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -656.634% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -738.67% |
| Rezolute, Inc. | 1.66 Million USD | -6684.639% |
| Clene Inc. | 7.15 Million USD | -1474.734% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -153448.836% |
| BeyondSpring Inc. | 3.36 Million USD | -3247.949% |
| Synlogic, Inc. | 12.49 Million USD | -801.649% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -244.883% |
| Krystal Biotech, Inc. | 6.62 Million USD | -1601.284% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | 34.106% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -1778.336% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -237650.945% |
| MannKind Corporation | 252.15 Million USD | 55.334% |
| Ikena Oncology, Inc. | 7.18 Million USD | -1468.593% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -56495.477% |
| Gossamer Bio, Inc. | 197.4 Million USD | 42.947% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -21558.654% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | 59.967% |
| Mural Oncology plc | 8.91 Million USD | -1163.887% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -157.511% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -7742.967% |
| Champions Oncology, Inc. | 6.09 Million USD | -1748.433% |
| REGENXBIO Inc. | 82.22 Million USD | -36.977% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -22698.445% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -2440.032% |
| Vaxart, Inc. | 2.62 Million USD | -4193.748% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -41362.499% |
| Cellectis S.A. | 36.24 Million USD | -210.767% |
| Longeveron Inc. | 1.44 Million USD | -7677.97% |
| Repare Therapeutics Inc. | 1.01 Million USD | -11050.99% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 90.055% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -151.569% |
| Revolution Medicines, Inc. | 80.57 Million USD | -39.777% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -3410.754% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -63529.944% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -91465.041% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 84.459% |
| Denali Therapeutics Inc. | 44.98 Million USD | -150.383% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -800.694% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -83264.792% |
| Passage Bio, Inc. | 22.92 Million USD | -391.362% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -1764.961% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -17307.264% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -458.517% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -22884.694% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -27540.954% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -9380.219% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -24068.455% |
| OmniAb, Inc. | 22.07 Million USD | -410.193% |
| Anew Medical, Inc. | 1.54 Million USD | -7213.312% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -281.005% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -1146.817% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -262.255% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -2677.942% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -118.448% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -1668.886% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -697.119% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -16659.673% |
| Alumis Inc. Common Stock | 30.86 Million USD | -264.955% |
| Equillium, Inc. | 384 Thousand USD | -29229.427% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -1728.625% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | 25.438% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -130.416% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -93518.56% |
| Dominari Holdings Inc. | 3.02 Million USD | -3619.452% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -569489.845% |
| vTv Therapeutics Inc. | 169 Thousand USD | -66542.012% |
| Bio-Techne Corporation | 319 Million USD | 64.694% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -97.629% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | 36.928% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -630.999% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -809.513% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -2242.937% |
| Nkarta, Inc. | 82.27 Million USD | -36.897% |
| BioCardia, Inc. | 982 Thousand USD | -11368.941% |
| Iterum Therapeutics plc | 18.95 Million USD | -494.139% |